亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州市紅旗化工有限公司  

醫藥原料醫藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 氟比洛芬 CAS:5104-49-4
氟比洛芬 CAS:5104-49-4
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 5104-49-4
過期 長期有效
更新 2020-06-18 10:08
 
詳細信息
氟比洛芬
CAS:5104-49-4
英文名稱:Flurbiprofen
中文別名:氟聯苯丙酸,氟苯布洛芬,氟布洛芬,苯氟布洛芬,風平片 
英文別名:Flurbiprofen;2-(2-fluorobiphenyl-4-yl)propanoic acid; Flurbiprofen axetil;
2-fluoro-alpha-methyl-4-biphenylacetic acid; 
2-Fluoro-[1,1'-biphenyl]-4-(alpha-methyl)acetic acid
含量:98%
分子式:C15H13FO2
分子量:244.26
性狀:白色結晶粉末,微刺激臭并有刺激味
標準:USP/BP/EP
用途:為消炎止痛退熱藥。用于治療風濕性關節炎,能明顯減輕癥狀。還可以用于牙科領域小手術后的鎮痛消炎
包裝:25kg/桶
©2025 隨州市紅旗化工有限公司 版權所有   技術支持:化工網   訪問量:31199  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |